vs
Addus HomeCare Corp（ADUS）とジーイー・ヘルスケア（OPCH）の財務データ比較。上の社名をクリックして会社を切り替えられます
ジーイー・ヘルスケアの直近四半期売上が大きい（$1.4B vs $373.1M、Addus HomeCare Corpの約3.8倍）。Addus HomeCare Corpの純利益率が高く（8.0% vs 3.6%、差は4.4%）。Addus HomeCare Corpの前年同期比売上増加率が高い（25.6% vs 12.2%）。ジーイー・ヘルスケアの直近四半期フリーキャッシュフローが多い（$130.2M vs $16.1M）。過去8四半期でAddus HomeCare Corpの売上複合成長率が高い（15.3% vs 13.0%）
Addus HomeCare Corpは米国に本拠を置く在宅ケアサービスプロバイダーで、高齢者、障がい者、慢性疾患患者を主な対象に、介護補助、在宅医療支援、ホスピスケアを提供しています。米国複数州で事業を展開し、公的保険運営元、民間保険会社、個人顧客と提携してニーズに合わせたサービスを届けています。
ジーイー・ヘルスケアは米国イリノイ州シカゴに本拠を置く医療テクノロジー企業で、医用画像（分子イメージング、CT、MRI、女性健診、X線装置を含む）、超音波、遠隔患者モニタリングや麻酔・呼吸ケア、心臓病診断、乳児ケアを手がける患者ケアソリューション、製薬関連の4つの事業部門を展開している。
ADUS vs OPCH — 直接比較
損益計算書 — Q4 2025 vs Q3 2025
| 指標 | | |
|---|---|---|
| 売上 | $373.1M | $1.4B |
| 純利益 | $29.8M | $51.8M |
| 粗利率 | 33.1% | 19.0% |
| 営業利益率 | 11.3% | 5.9% |
| 純利益率 | 8.0% | 3.6% |
| 売上前年比 | 25.6% | 12.2% |
| 純利益前年比 | 52.5% | -3.8% |
| EPS（希薄化後） | $1.62 | $0.32 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $373.1M | — | ||
| Q3 25 | $362.3M | $1.4B | ||
| Q2 25 | $349.4M | $1.4B | ||
| Q1 25 | $337.7M | $1.3B | ||
| Q4 24 | $297.1M | $1.3B | ||
| Q3 24 | $289.8M | $1.3B | ||
| Q2 24 | $286.9M | $1.2B | ||
| Q1 24 | $280.7M | $1.1B |
| Q4 25 | $29.8M | — | ||
| Q3 25 | $22.8M | $51.8M | ||
| Q2 25 | $22.1M | $50.5M | ||
| Q1 25 | $21.2M | $46.7M | ||
| Q4 24 | $19.5M | $60.1M | ||
| Q3 24 | $20.2M | $53.9M | ||
| Q2 24 | $18.1M | $53.0M | ||
| Q1 24 | $15.8M | $44.8M |
| Q4 25 | 33.1% | — | ||
| Q3 25 | 32.2% | 19.0% | ||
| Q2 25 | 32.6% | 19.0% | ||
| Q1 25 | 31.9% | 19.7% | ||
| Q4 24 | 34.2% | 21.3% | ||
| Q3 24 | 31.8% | 20.1% | ||
| Q2 24 | 32.5% | 20.3% | ||
| Q1 24 | 31.4% | 20.8% |
| Q4 25 | 11.3% | — | ||
| Q3 25 | 9.1% | 5.9% | ||
| Q2 25 | 9.4% | 5.8% | ||
| Q1 25 | 9.0% | 5.9% | ||
| Q4 24 | 9.1% | 6.9% | ||
| Q3 24 | 9.0% | 6.7% | ||
| Q2 24 | 9.1% | 6.6% | ||
| Q1 24 | 8.4% | 6.0% |
| Q4 25 | 8.0% | — | ||
| Q3 25 | 6.3% | 3.6% | ||
| Q2 25 | 6.3% | 3.6% | ||
| Q1 25 | 6.3% | 3.5% | ||
| Q4 24 | 6.6% | 4.8% | ||
| Q3 24 | 7.0% | 4.2% | ||
| Q2 24 | 6.3% | 4.3% | ||
| Q1 24 | 5.6% | 3.9% |
| Q4 25 | $1.62 | — | ||
| Q3 25 | $1.24 | $0.32 | ||
| Q2 25 | $1.20 | $0.31 | ||
| Q1 25 | $1.16 | $0.28 | ||
| Q4 24 | $1.06 | $0.36 | ||
| Q3 24 | $1.10 | $0.31 | ||
| Q2 24 | $1.10 | $0.30 | ||
| Q1 24 | $0.97 | $0.26 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | — | $309.8M |
| 総負債低いほど良い | $121.0M | $1.2B |
| 株主資本純資産 | $1.1B | $1.4B |
| 総資産 | $1.4B | $3.5B |
| 負債/資本比率低いほどレバレッジが低い | 0.11× | 0.86× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | — | — | ||
| Q3 25 | — | $309.8M | ||
| Q2 25 | — | $198.8M | ||
| Q1 25 | $97.0M | $171.4M | ||
| Q4 24 | $98.9M | $412.6M | ||
| Q3 24 | $222.9M | $483.0M | ||
| Q2 24 | $173.3M | $376.9M | ||
| Q1 24 | $76.7M | $219.5M |
| Q4 25 | $121.0M | — | ||
| Q3 25 | $150.6M | $1.2B | ||
| Q2 25 | $169.1M | $1.1B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | $218.4M | $1.1B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $1.1B |
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.0B | $1.4B | ||
| Q2 25 | $1.0B | $1.4B | ||
| Q1 25 | $995.4M | $1.4B | ||
| Q4 24 | $970.5M | $1.4B | ||
| Q3 24 | $947.6M | $1.4B | ||
| Q2 24 | $921.7M | $1.4B | ||
| Q1 24 | $725.1M | $1.4B |
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | $3.5B | ||
| Q2 25 | $1.4B | $3.4B | ||
| Q1 25 | $1.4B | $3.3B | ||
| Q4 24 | $1.4B | $3.4B | ||
| Q3 24 | $1.2B | $3.4B | ||
| Q2 24 | $1.1B | $3.3B | ||
| Q1 24 | $1.0B | $3.2B |
| Q4 25 | 0.11× | — | ||
| Q3 25 | 0.14× | 0.86× | ||
| Q2 25 | 0.17× | 0.82× | ||
| Q1 25 | — | 0.82× | ||
| Q4 24 | 0.23× | 0.79× | ||
| Q3 24 | — | 0.78× | ||
| Q2 24 | — | 0.79× | ||
| Q1 24 | — | 0.74× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $18.8M | $139.4M |
| フリーキャッシュフロー営業CF - 設備投資 | $16.1M | $130.2M |
| FCFマージンFCF / 売上 | 4.3% | 9.1% |
| 設備投資強度設備投資 / 売上 | 0.7% | 0.6% |
| キャッシュ転換率営業CF / 純利益 | 0.63× | 2.69× |
| 直近12ヶ月FCF直近4四半期 | $103.8M | $220.7M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $18.8M | — | ||
| Q3 25 | $51.3M | $139.4M | ||
| Q2 25 | $22.5M | $90.3M | ||
| Q1 25 | $18.9M | $-7.2M | ||
| Q4 24 | $10.4M | $36.1M | ||
| Q3 24 | $48.5M | $160.4M | ||
| Q2 24 | $18.8M | $195.7M | ||
| Q1 24 | $38.7M | $-68.8M |
| Q4 25 | $16.1M | — | ||
| Q3 25 | $49.3M | $130.2M | ||
| Q2 25 | $21.3M | $81.2M | ||
| Q1 25 | $17.1M | $-16.6M | ||
| Q4 24 | $8.7M | $25.8M | ||
| Q3 24 | $46.6M | $150.7M | ||
| Q2 24 | $17.7M | $185.9M | ||
| Q1 24 | $37.3M | $-74.6M |
| Q4 25 | 4.3% | — | ||
| Q3 25 | 13.6% | 9.1% | ||
| Q2 25 | 6.1% | 5.7% | ||
| Q1 25 | 5.1% | -1.2% | ||
| Q4 24 | 2.9% | 2.0% | ||
| Q3 24 | 16.1% | 11.8% | ||
| Q2 24 | 6.2% | 15.1% | ||
| Q1 24 | 13.3% | -6.5% |
| Q4 25 | 0.7% | — | ||
| Q3 25 | 0.5% | 0.6% | ||
| Q2 25 | 0.4% | 0.6% | ||
| Q1 25 | 0.6% | 0.7% | ||
| Q4 24 | 0.6% | 0.8% | ||
| Q3 24 | 0.7% | 0.8% | ||
| Q2 24 | 0.4% | 0.8% | ||
| Q1 24 | 0.5% | 0.5% |
| Q4 25 | 0.63× | — | ||
| Q3 25 | 2.24× | 2.69× | ||
| Q2 25 | 1.02× | 1.79× | ||
| Q1 25 | 0.89× | -0.15× | ||
| Q4 24 | 0.53× | 0.60× | ||
| Q3 24 | 2.41× | 2.98× | ||
| Q2 24 | 1.04× | 3.69× | ||
| Q1 24 | 2.44× | -1.54× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ADUS
| Personal Care | $286.0M | 77% |
| Hospice | $70.0M | 19% |
| Home Health | $17.1M | 5% |
OPCH
| Commercial Customer | $1.3B | 87% |
| Government Customer | $172.8M | 12% |
| Patient Customer | $10.1M | 1% |
| Corporate Joint Venture | $1.9M | 0% |
